UPTD
NASDAQTradeUP Acquisition Corp.
TradeUP Acquisition Corp. (UPTD) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for UPTD in the last 30 days. The most recent was published Feb 14, 2024.
Latest news
25 items- SECSEC Form 10-Q filed by TradeUP Acquisition Corp.10-Q - Estrella Immunopharma, Inc. (0001844417) (Filer)
- SECSEC Form 424B3 filed by TradeUP Acquisition Corp.424B3 - Estrella Immunopharma, Inc. (0001844417) (Filer)
- SECTradeUP Acquisition Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - Estrella Immunopharma, Inc. (0001844417) (Filer)
- SECTradeUP Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Estrella Immunopharma, Inc. (0001844417) (Filer)
- SECSEC Form EFFECT filed by TradeUP Acquisition Corp.EFFECT - Estrella Immunopharma, Inc. (0001844417) (Filer)
- SECSEC Form 424B3 filed by TradeUP Acquisition Corp.424B3 - Estrella Immunopharma, Inc. (0001844417) (Filer)
- SECSEC Form S-1/A filed by TradeUP Acquisition Corp. (Amendment)S-1/A - Estrella Immunopharma, Inc. (0001844417) (Filer)
- SECSEC Form 10-Q filed by TradeUP Acquisition Corp.10-Q - Estrella Immunopharma, Inc. (0001844417) (Filer)
- SECSEC Form NT 10-Q filed by TradeUP Acquisition Corp.NT 10-Q - Estrella Immunopharma, Inc. (0001844417) (Filer)
- SECSEC Form S-1/A filed by TradeUP Acquisition Corp. (Amendment)S-1/A - Estrella Immunopharma, Inc. (0001844417) (Filer)
- 13D/GSEC Form SC 13D filed by TradeUP Acquisition Corp.SC 13D - Estrella Immunopharma, Inc. (0001844417) (Subject)
- SECSEC Form S-1 filed by TradeUP Acquisition Corp.S-1 - Estrella Immunopharma, Inc. (0001844417) (Filer)
- INSIDERNew insider Xu Jiandong claimed ownership of 264,388 shares (SEC Form 3)3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
- INSIDERSEC Form 3 filed by new insider Roberts Marsha3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
- INSIDERSEC Form 3 filed by new insider Xu Pei3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
- INSIDERNew insider Liu Cheng claimed ownership of 297,437 shares (SEC Form 3)3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wu Xuejun Janelle3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wu Fan3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
- INSIDERNew insider Eureka Therapeutics, Inc. claimed ownership of 25,277,831 shares (SEC Form 3)3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
- SECTradeUP Acquisition Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Amendments to the Registrant's Code of Ethics, or Waiver o8-K - Estrella Immunopharma, Inc. (0001844417) (Filer)
- INSIDEROwl Creek Asset Management, L.P. disposed of $2,769,300 worth of shares (255,000 units at $10.86) (SEC Form 4)4 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
- SECSEC Form 25-NSE filed by TradeUP Acquisition Corp.25-NSE - Estrella Immunopharma, Inc. (0001844417) (Subject)
- INSIDERSEC Form 4 filed by Tradeup Acquisition Sponsor Llc4 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
- INSIDERSEC Form 4 filed by Long James4 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
- INSIDERSEC Form 4 filed by Wen Luqi4 - Estrella Immunopharma, Inc. (0001844417) (Issuer)
UPTD FAQ
6 questionsWhat is the latest news on UPTD?
Quantisnow has not tracked any new filings, ratings or press releases for UPTD in the last 30 days. The most recent wire item was published on February 14, 2024.Where does UPTD stock trade?
TradeUP Acquisition Corp. (UPTD) is listed on NASDAQ.What sector and industry is UPTD in?
TradeUP Acquisition Corp. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did TradeUP Acquisition Corp. go public?
TradeUP Acquisition Corp. (UPTD) completed its IPO in 2021.What companies are similar to UPTD?
Notable peers in the same industry include AMGN (Amgen Inc.), ARGX (argenx SE), MRNA (Moderna Inc.), RVMD (Revolution Medicines Inc.), GILD (Gilead Sciences Inc.). Compare UPTD side-by-side with any of them on Quantisnow.How can I track UPTD on Quantisnow?
Quantisnow aggregates TradeUP Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow UPTD to receive live email and push alerts on every new disclosure.